Exosome-mediated circ-HIPK3 enhances TMZ resistance via modulating the miR-421/ZIC5 axis and promotes tumorigenesis in vitro and in vivo; its expression in serum exosomes can be used as a biomarker for diagnosis of TMZ-resistant glioma [85]. The gene discussed is HIPK3; the disease is central nervous system cancer.